Sep 29, 2023

Inside the Issue: Optimizing the Management of Metastatic BRCA-Negative, Triple-Negative Breast Cancer | Faculty Presentation 2: Current and Future Role of Nonbiomarker-Based Strategies for Patients with Metastatic BRCA-Negative TNBC — Hope S Rugo, MD

CME information and select...

Sep 29, 2023

Inside the Issue: Optimizing the Management of Metastatic BRCA-Negative, Triple-Negative Breast Cancer | Faculty Presentation 1: Biomarker-Based Decision-Making for Patients with Metastatic BRCA-Negative, Triple-Negative Breast Cancer (TNBC) — Tiffany A Traina, MD, FASCO

CME information and select...

Sep 29, 2023

Featuring perspectives from Dr Hope S Rugo and Dr Tiffany Traina, including the following topics:

• Introduction: “Isn’t Oncology Depressing?” (0:00)
• Checkpoint Inhibitors (13:37)
• Antibody-Drug Conjugates (30:04)
• HER2-Low Disease (54:25)
• Other Agents Under Development (59:54)

CME information and select...

Sep 28, 2023

Featuring an interview with Dr Paul G Richardson, including the following topics:

• Biologic rationale for targeting protein degradation pathways as a therapeutic approach in multiple myeloma (MM); mechanism of action of CELMoDs (0:00)
• Similarities and differences between iberdomide, mezigdomide and standard...

Sep 28, 2023

Featuring a slide presentation and related discussion from Dr Paul G Richardson, including the following topics:

• Biologic rationale for targeting protein degradation pathways as a therapeutic approach in multiple myeloma (MM); mechanism of action of CELMoDs (0:00)
• Published efficacy and safety findings...